What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CHADS₂ Score Calculation

This patient has a CHADS₂ score of 5 points, placing him at very high risk for stroke with an annual stroke rate of approximately 12.5%.

Score Breakdown

The CHADS₂ scoring system assigns points as follows 1:

  • C (Congestive Heart Failure): 1 point - Present (high JVP, S3 heart sound, bi-basal crackles indicate acute decompensated heart failure) 1
  • H (Hypertension): 1 point - Present (known hypertensive, current BP 150/90 mmHg) 1
  • A (Age ≥75 years): Cannot determine from "[AGE]-year-old" - assign 0 or 1 point depending on actual age 1
  • D (Diabetes Mellitus): 1 point - Present (known diabetic) 1
  • S₂ (Prior Stroke/TIA): 2 points - Present (history of stroke) 1

Risk Stratification

If age <75 years: CHADS₂ score = 5 points

  • Annual stroke risk: 12.5% (95% CI 8.2-17.5%) 1

If age ≥75 years: CHADS₂ score = 6 points

  • Annual stroke risk: 18.2% (95% CI 10.5-27.4%) 1

Clinical Implications

This patient requires immediate oral anticoagulation with warfarin (target INR 2.0-3.0) given the CHADS₂ score ≥2. 1 The combination of prior stroke (which alone assigns 2 points and mandates anticoagulation) plus multiple additional risk factors creates an extremely high thromboembolic risk 1.

Critical Management Points

  • Prior stroke history is the most powerful predictor, warranting anticoagulation regardless of other factors 2
  • The acute heart failure presentation (evidenced by high JVP, S3, bi-basal crackles, hypoxemia) requires stabilization before initiating anticoagulation 1
  • Blood pressure control is critically important before starting anticoagulation, as intracerebral hemorrhage risk is exquisitely sensitive to BP control 2
  • The current tachycardia (HR 144/min) requires rate control as part of acute AF management 1

Treatment Algorithm

  1. Immediate: Rate control for AF with HR 144/min, treat acute heart failure 1
  2. Within 24-48 hours: Initiate oral anticoagulation once hemodynamically stable and BP controlled 1
  3. Target INR 2.0-3.0 with warfarin, or consider direct oral anticoagulants as alternative 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Atrial Fibrillation Stroke Risk Assessment using CHADS₂ Score

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

CHA₂DS₂-VASc Risk Stratification for Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the CHADS2 (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischemic attack) score for a patient with atrial fibrillation, congestive heart failure, hypertension, diabetes mellitus, and a history of stroke, presenting with dyspnea, shortness of breath, palpitations, irregular pulse, high jugular venous pressure (JVP), S3 heart sound, bi-basal crackles, tachycardia, and hypoxemia?
How is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score interpreted?
What is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age, Diabetes, Stroke, Vascular disease, and Sex category) score for a 64-year-old male patient with Diabetes Mellitus (DM), Hypertension (HTN), Congestive Heart Failure (CHF), and a history of stroke, presenting with atrial fibrillation?
What is the CH2DS2-VASc (Congestive heart failure, Hypertension, 2 points for age ≥75 years, Diabetes, Stroke/Transient ischemic attack/thromboembolism, Vascular disease, Age 65-74 years, Sex category) score for an older male, ≥75 years, with a history of stroke, but otherwise medically free?
What is the role of the CHADS₂ (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack) score in assessing stroke risk in patients with atrial fibrillation?
What is the management of a patient with thyrotoxicosis (a condition characterized by excessive levels of thyroid hormones) complicated by shock?
What are the stages of iron toxicity in a pediatric patient under 6 years old with suspected iron overdose?
What is the best management plan for a 64-year-old female patient, ex-smoker, with a history of malignant melanoma, lentigo maligno, and adenopathy, who refuses exenteration ocular and has multiple comorbidities?
Is megestrol (a progestin) a suitable treatment option for a patient experiencing heavy vaginal bleeding?
Is jejunostomy (surgical creation of an opening in the jejunum) a suitable treatment option for a patient with a massive hepatic (liver) hematoma?
What is the dosing for cyclic progestins (progestin), such as norethindrone or medroxyprogesterone, for a woman of reproductive age with menorrhagia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.